Back to Journals » International Journal of Nanomedicine » Volume 11

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer

Total article views   Abstract views HTML views PDF downloads Totals
9,182 Dovepress* 4,808 3,273+ 1,317 8,081
PubMed Central* 0 1,101 311 1,101
Totals 4,808 4,374 1,628 9,182
*Since 8 January 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar